SOTAC
Invest Now
Start SIP in
SOTAC
Performance
- Low
- ₹119
- High
- ₹125
- 52 Week Low
- ₹87
- 52 Week High
- ₹203
- Open Price₹119
- Previous Close₹125
- Volume2,400
Investment Returns
- Over 1 Month + 5.22%
- Over 3 Month + 19%
- Over 6 Month -0.04%
- Over 1 Year + 1.59%
Smart Investing Starts Here Start SIP with Sotac Pharmaceuticals Ltd for Steady Growth!
Sotac Pharmaceuticals Ltd Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 38.6
- PEG Ratio
- -
- Market Cap Cr
- 138
- P/B Ratio
- 2.9
- Average True Range
- 4.28
- EPS
- 4.16
- Dividend Yield
- 0
- MACD Signal
- 3.77
- RSI
- 58.03
- MFI
- 91.85
Sotac Pharmaceuticals Ltd Financials
Sotac Pharmaceuticals Ltd Technicals
EMA & SMA
Current Price
₹124.95
-0.05
(-0.04%)

-
- Bearish Moving Average 3
-
- Bullish Moving Average 13
- 20 Day
- ₹119.96
- 50 Day
- ₹117.93
- 100 Day
- ₹121.77
- 200 Day
- ₹124.87
Resistance and Support
122.88
- R3 133.22
- R2 129.08
- R1 127.02
- S1 120.82
- S2 116.68
- S3 114.62
Sotac Pharmaceuticals Ltd Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-10-29 | Quarterly Results | |
2024-08-13 | Quarterly Results | |
2024-05-17 | Audited Results & Others | To consider other business matters |
2023-11-06 | Quarterly Results | |
2023-05-29 | Audited Results |
Sotac Pharmaceuticals Ltd F&O
About Sotac Pharmaceuticals Ltd
- NSE Symbol
- SOTAC
- BSE Symbol
- Chairman & Managing Director
- Mr. Sharadkumar Dashrathbhai Patel
- ISIN
- INE0O2D01012
Similar Stocks to Sotac Pharmaceuticals Ltd
Sotac Pharmaceuticals Ltd FAQs
Sotac Pharmaceuticals Ltd share price is ₹124 As on 02 May, 2025 | 11:42
The Market Cap of Sotac Pharmaceuticals Ltd is ₹138.1 Cr As on 02 May, 2025 | 11:42
The P/E ratio of Sotac Pharmaceuticals Ltd is 38.6 As on 02 May, 2025 | 11:42
The PB ratio of Sotac Pharmaceuticals Ltd is 2.9 As on 02 May, 2025 | 11:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.